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Background: Chronic pelvic pain (CPP) is a complex pain syndrome. Since its pathogenesis is still 
poorly understood and structural alterations in pain related brain regions may be present, there is 
a greater acceptance that sensitization of the central nervous system (CNS) plays an important role 
in the development and maintenance of chronicity. 
Objective: The purpose of this study is to systematically review the scientific evidence regarding 
central sensitization (CS) in female patients with urogynecological CPP.
Study Design: Systematic review of the literature.
Methods: A systematic literature search was conducted in PubMed and Web of Science using 
different keyword combinations related to urogynecological CPP and central sensitization. Full 
text clinical reports addressing CS in adult women with urogynecological CPP were included and 
assessed for methodological quality by 2 independent reviewers.
Results: After screening for the eligibility, a total of 29 full-text articles with low to good 
methodological quality were retained. All studies were observational, 27 of which were case-
control and 2 of which were cohorts. Sensitivity of the CNS was investigated by using a variety 
of methods. Although different central mechanisms seem to be involved in pain processing, the 
present evidence suggests hyperexcitability of the CNS in patients with urogynecological CPP. 
Altered brain morphology and function, generalized hyperalgesia to different type of stimuli, 
overactive bottom-up nociceptive mechanisms, and autonomic dysregulation were established 
in patients with urogynecological CPP. Nevertheless, diffuse noxious inhibitory control seemed 
normal, and therefore the contribution of an impaired endogenous pain inhibition mechanism to 
CPP requires further study. The same goes for the contribution of psychological factors.
Limitations: The level of evidence of retained studies is low due to the observational study 
designs and a wide range of diagnoses and assessment methods.
Conclusion: Although the majority of the literature provides evidence for the presence of CS in 
urogynecological CPP with changes in brain morphology/function and sensory function, it is unclear 
whether these changes in central pain processing are secondary or primary to CPP, especially since 
evidence regarding the function of endogenous pain inhibition and the role of psychosocial pain 
facilitation is scarce. Further studies with good methodological quality are needed in order to clarify 
exact mechanisms.
Key words: Urogynecological pain, pelvic pain, chronic pelvic pain, hyperalgesia, sensitization, 
central sensitization, pain processing, pain modulation, pain inhibition, systematic review
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In visceral hyperalgesia, visceral stimuli that are 
normally sub-threshold may be perceived in the case of 
CS (28). Of particular importance is that these changes 
may result in sensory and functional abnormalities not 
only of the end organ subjected to initiating factors, 
but also of other organs within the region. This cross-
talk between the organs is complicated and can prob-
ably happen in any direction (27,29). Cross-sensitization 
among pelvic structures may contribute to CPP of un-
known etiology and involves convergent neural path-
ways of noxious stimulus transmission from 2 or more 
organs (viscero-visceral sensitization). Besides the vis-
cera, somatic areas may also be involved. Given enough 
time, trigger points can develop in peripheral somatic 
tissue in response to increased nociceptive visceral 
input (viscero-somatic sensitization) (2,30). Especially 
increased sensitivity at asymptomatic remote areas, 
referred to as secondary hyperalgesia, rather than pri-
mary hyperalgesia (at asymptomatic places), is sugges-
tive for CS (31). In addition, CS entails much more than 
generalized hypersensitivity to pain: It is characterized 
by an increased responsiveness to a variety of stimuli 
including mechanical pressure (32), chemical substances 
(33), cold (34), heat (20), electrical stimuli (32,35), stress, 
emotions, and mental load (15).
In summary, like many chronic disabling pain 
syndromes, CPP may be the result of an incompletely 
understood dysfunction in peripheral and/or central 
neural processing (36). Although, it has already been 
suggested that many of the mechanisms for the CPP 
syndromes are based within the CNS (37), there is a 
need to evaluate and summarize findings of the 
literature.
To the best of our knowledge, studies evaluating 
CS in urogynecological CPP have not been reviewed sys-
tematically until now. Therefore, the aim of the present 
study is to systematically review the current evidence 
regarding central nociceptive processing in women 
with urogynecological CPP. It is hypothesized that the 
sensitization of the CNS is responsible for the develop-
ment and/or maintenance of pain and other symptoms.
Methods
This systematic review is reported following the 
PRISMA (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses) guidelines which is an up-
dated reporting guidance addressing the conceptual, 
methodological, and practical issues of the original 
Quality of Reporting of Meta-analyses (QUOROM) 
Statement (38). 
Chronic pelvic pain (CPP) is defined as chronic or persistent pain perceived in structures related to the pelvis for at least 6 months 
(1). Like many other chronic pain syndromes, CPP is a 
multifactorial condition with possible sources of pain 
located in the urogynecological, gastrointestinal, 
musculoskeletal, and/or in the nervous system, making 
the differential diagnosing challenging (2). 
This multifactorial trait means that CPP mecha-
nisms may include ongoing acute peripheral pain 
mechanisms involving somatic or visceral tissue, 
chronic pain mechanisms which especially involve the 
central nervous system (CNS) and emotional, cogni-
tive, behavioral, and sexual responses and mecha-
nisms (3-6).  
Although in the majority of cases of CPP, ongo-
ing tissue trauma, inflammation, or infection are not 
identifiable (7-11), conditions that cause recurrent 
trauma, infection, or ongoing inflammation may re-
sult in CPP in a small proportion of cases. Activation 
of acute pain mechanisms by a nociceptive event may 
sensitize peripheral nociceptive afferents, magnifying 
the afferent signaling (12,13).
While peripheral sensitization is a local phenom-
enon, central sensitization (CS) is a central process of 
the nervous system with the enhanced responsiveness 
of the central neurons to input from unimodal and po-
limodal receptors (14-16). This central hypersensitivity 
could also explain the chronic pain in the absence 
of peripheral pathology (17) and the discrepancy 
between the magnitude of tissue damage and magni-
tude of pain and disability in CPP syndrome (18). 
CS indeed encompasses altered sensory processing 
in the brain (19), malfunctioning of descending pain 
inhibitory mechanisms (20), increased activity of pain 
facilitatory pathways, temporal summation of second 
pain or wind-up (19,21), and long-term potentiation 
of neuronal synapses in the anterior cingulate cortex 
(22). Both top-down and bottom-up mechanisms play 
an important role in the pathophysiology of CS. For 
example, peripheral injury or other stressors trigger 
the release of proinflammatory cytokines, with the 
consequent activation of spinal cord glia with cyclo-
oxygenase-2 and prostaglandin E2 expression in the 
CNS (23-26). The outcome of these changes within the 
peripheral nervous system and CNS is a hypersensitive 
state and amplification of perception of a peripheral 
stimulus; painful perception of nonpainful stimuli (al-
lodynia) and increased sensitivity for painful stimuli 
(hyperalgesia) (1,27). 
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Eligibility Criteria
To be included in the present systematic review, 
papers had to report the results of clinical studies (S) 
evaluating the clinical, radiologic, and neurophysiologic 
manifestations of CS (I), assessed by experimental out-
come measures (O), in women with urogynecological 
CPP (P), compared to healthy controls (C).
More specifically, an article had to meet following 
eligibility criteria: (1) human adult women (> 18 years) 
suffering from urogynecological CPP were evaluated; 
(2) central pain processing was assessed; (3) patients 
were compared to healthy controls; (4) published in 
English in the last 20 years; and (5) full-text reports, and 
not abstracts, case-reports, letters, or editorials. The 
studies not fulfilling any of the 5 inclusion criteria were 
excluded. The articles assessing only primary hyperal-
gesia or peripheral sensitization were not included, as 
these are not supposed to represent CS (31).
Information Sources and Search Strategy
To identify relevant articles regarding CS in urogy-
necological CPP, PubMed (www.ncbi.nlm.nih.gov/sites/
entrez) and Web of Science (http://apps.webofknowl-
edge.com) were searched. The last search was run on 
November 14, 2012. Two groups of key words were de-
termined related to “urogynecological CPP” and “cen-
tral sensitization.” Key words from group 1 were com-
bined with key words from group 2. The construct of 
the search strategy is presented in Table 1. Additionally, 
the reference lists of all included full-text reports were 
hand searched. Literature search was developed by the 
first author (SK), who achieved the degree of Master 
of Science, is experienced in pelvic physiotherapy, and 
was trained in conducting a systematic review by the 
last author (MM), who obtained the degree of PhD with 
a dissertation regarding chronic pain and CS  and has 
published 4 systematic reviews in this domain (39-42). 
Data Collection Process
At first, the studies were screened according to 
the title and abstract with the inclusion and exclusion 
criteria. As a second step, the remaining papers were 
screened on a full-text basis.
Data Items
Information was extracted from each included trial 
on: 1) characteristics of trial participants (including diag-
nosis, age, and pain duration) and the study’s inclusion 
and exclusion criteria, 2) method of assessment (brain 
imaging, neurophysiological tests, quantitative sensory 
tests, subjective pain ratings, psychosocial measures, 
etc.), 3) type of outcome measure (brain morphology/
function, sensation/pain threshold or tolerance, pain 
ratings, psychosocial scores, etc.) and 4) main results. 
The first author (SK) extracted the data from included 
studies and the last author (MM) reviewed the ex-
tracted data.
Risk of Bias in Individual Studies
Methodological quality was assessed by 2 inde-
pendent researchers (SK and LH), who were blinded 
to each others assessments. The second rater was also 
trained in assessing methodological quality. In case of 
uncertainty between these 2 raters, a third decisive 
opinion was provided by the last author (MM).
Methodological quality was evaluated using 
Newcastle-Ottawa Scale (NOS). The NOS has been rec-
ommended by the Cochrane Non-Randomized Studies 
Methods Working Group and it is partly validated and 
primarily used to appraise cohort studies and case-
control studies (43,44). The NOS uses a star rating sys-
tem (range 0 to 9 stars)  to judge the quality of a study 
based on 3 broad perspectives: the selection of the study 
groups, the comparability of the groups, and the ascer-
tainment of either the exposure or outcome of interest 
for case-control or cohort studies respectively (44). 
Table 1. Search strategy
Keywords
Group 1 Group 2
pelvic pain OR
chronic pelvic pain OR
dysmenorrhea OR
endometriosis OR
adenomyosis OR
interstitial cystitis OR
painful bladder syndrome OR
bladder pain syndrome OR
urethral pain syndrome OR
genital pain syndrome OR
vaginal pain syndrome OR
vulvar pain syndrome OR
vulvodynia OR
vulvar vestibulitis syndrome OR
perineal pain syndrome OR
vaginismus OR
pudendal neuralgia OR
pudendal pain syndrome OR
pelvic floor muscle pain OR
myofascial pelvic floor 
dysfunction OR
myofascial pelvic pain syndrome 
OR
pelvic organ prolapse
sensitization OR
(sensitization AND 
hyperalgesia) OR
peripheral sensitization OR
central sensitization OR
(sensitization AND algometry) 
OR
(pain threshold AND central) 
OR
quantitative sensory testing OR
central sensitivity OR
central hypersensitivity OR
central hyperexcitability OR
pain processing OR
pain modulation OR
neural inhibition OR
nociception OR
hyperalgesia OR
allodynia OR
windup OR
temporal summation OR
spatial summation OR
conditioned pain modulation
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Level of Evidence
After pooling the results, the overall quality of 
evidence for each outcome was rated with the Grades 
of Recommendation, Assessment, Development, and 
Evaluation (GRADE) approach (45).
Grading the evidence was done by 3 researchers 
(SK, TW, and MM) by means of internal discussion and 
consensus.  
Results
Study Selection and Study Characteristics
The flow-chart in Figure 1 shows the selection 
process. The initial search resulted in 805 hits. Finally, 
29 full-text articles were included in the qualitative 
synthesis of this review. Of the 29 articles, 27 were case 
control studies and 2 were cohort studies. The charac-
teristics of the included studies are presented in Table 2.
Fig. 1. Flow chart study selection
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Table 2. Evidence table
Studies/ 
Design/ NOS
Patients (P); Age; Pain 
Duration
Controls 
(C)
Outcome Measures Main Results
Sutton et al
(2012) (54)/
Case control/
NOS (5)
Provoked vestibulodynia; 
23.78±5.04 (18-36); 3.66  
(0.75-10); n= 23
26.52±8.56 
(19-44); n= 
23
•   Pain intensity ratings during 
gynecological examination
•   HPT, HP-Tol, ratings for  pain 
tolerance
•   Peak pain ratings during 
temporal summation 
procedure
P↔C
•   ↑ pain intensity ratings during gynecological 
examination
•   ↓ HP-Tol before conditioning stimulus
•   ↑ magnitude of DNIC responding
P = C
•   HPT 
•   HP-Tol during conditioning stimulus
•   Ratings for pain tolerance before or during 
conditioning stimulus
•   Peak pain ratings before or during conditioning 
stimulus in the number of  DNIC responders
As-Sanie et al 
(2012) (17)/
Case control/
NOS (7)
1. Endometriosis (+) CPP 
(+); 
26.1±1.5; 5.5 [3.5-9.5]; 
n= 17
2. Endometriosis (+) CPP 
(-); 
36.8±2.2;  0[0,0]; n= 15
3. Endometriosis (-) CPP 
(+) ; 24.2±1.9;  3.75[0.90-
9.9]; n= 6
25.9±1.6; 
n=17
36.2±2.6; 
n= 14
24.8±1.2; 
n= 12
•   Gray matter (GM) volume 
in regions involved in pain 
processing
•   Clinical pain; pain intensity 
and unpleasantness
•   Experimental pain testing; 
pressure- pain values required 
to elicit faint, mild and 
slightly intense pain
•   Measures of mood and 
function 
P1, P3↔C
•   ↓ GM volume 
P2↔C
•   ↑ GM volume 
Zhang et al
(2011) (56)/
Case control/
NOS (4)
Vulvodynia; n= 12
1. Women with a shorter 
history of pain
34.6±4.3; 3.4±1.3; n= 5
2. Women with a longer 
history of pain
35.7±3.2; 9.3±1.4; n= 7
-
n= 20
•   Vibrotactile detection 
threshold
•   Amplitude discrimination 
capacity
•   A metric of adaptation (the 
impact of conditioning 
stimuli on amplitude 
discrimination capacity)
P2↔ (P1=C)
•   ↓ adaptation metric
P1=P2=C
•   Vibrotactile detection threshold
•   Amplitude discrimination capacity
Vincent et al
(2011) (50)/
Case control/
NOS (4)
Dysmenorrhea; 30±7; no 
years menstruation:
17±6; n= 12
32±10; 
no years 
menstruation: 
19±10; n= 12
•   Behavioral measures
*  the temperature needed to 
obtain a pain intensity 5 of 10
*  pain intensity and 
unpleasantness ratings during 
heat stimulation
•   Serum cortisol levels
•   Brain activity with FMRI
•   Psychological profile and 
quality of life
P↔C
•   ↓ temperature 
•   ↓ serum cortisol levels
•   no deactivation of  brain regions during 
menstrual phase
•   ↑ brain activity (entorhinal cortex)  during 
nonmenstrual phases
•   ↓ quality of life
P=C
•   pain intensity and unpleasantness ratings
•   brain activity during menstrual phase
Neziri et al
(2010) (18)/
Case control/
NOS (5)
Endometriosis; 33{30-36}; 
> 6 month; n= 20
27{24-37}; 
n= 25
•   Reflex receptive fields
•   Pain and nociceptive 
withdrawal reflex thresholds 
after a single and during 
repeated electrical stimulation
•   Measures of  mood and 
function
P↔C
•   ↑ reflex receptive field areas
•   ↓ thresholds for the subjective feeling of  pain 
/increasing pain sensation and to evoke a 
nociceptive reflex after a single stimuli and 
during repeated stimulation
He et al
(2010) (70)/
Cohort/
NOS (7)
Endometriosis; 34.4±7.4; 33 
(23-52); n= 100; PD Ø
33.4±7.1; 
32 (25-51); 
n= 70
•   Dysmenorrhea (DM ) 
severity 
•   Electrical pain test (EPT) 
sensory and pain threshold
•   The pain intensity score that 
matches with patients own 
DM severity
•   Ischemic pain test (IPT)
Before surgery
P↔C
•  ↓ EPT pain threshold
•  ↑ IPT scores
P=C
•  EPT sensory threshold
6 months after surgery
P=C
•  IPT scores
•  EPT sensory and pain thresholds
Post-op 6th month↔Pre-op
•  ↓ DM severity 
•  ↓ EPT DM matching score
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Studies/ 
Design/ NOS
Patients (P); Age; Pain 
Duration
Controls 
(C)
Outcome Measures Main Results
 Tu et al
(2010) (46)/
Case control
NOS (7)
Primary dysmenorrhea; 
23.84±2.99; 10.19±3.25; 
n=32
23.81±2.80; 
n=32;
•   Psychological measures 
•   Total and regional gray 
matter (GM) volume
P = C
•  psychological measures
•  total GM volume
P↔C
•   ↓ GM  volume in regions involved in pain 
transmission, higher level sensory processing, 
and affect regulation
•   ↑ GM volume in regions involved in pain 
modulation and regulation function of endocrine
Sutton et al
(2009) (53)/
Case control/
NOS (6)
Provoked vestibulodynia; 
26.08±8.34; 3.77±2.93 (0.8-
10.0); n= 20
23.72±4.90; 
n= 25
•   Pain intensity ratings during 
gynecological examination
•   QST (PPT, HD, HPT, HP-
Tol), pain/sensory  intensity 
and unpleasantness during 
QST
•   Psychosocial measures
P↔C
•   ↑ pain intensity ratings during gynecological 
examination
•   ↓ vulvar PPTs, HPTs, HP-Tols
•   ↑ self-report ratings for HD
•   ↑ somatization, catastrophization
•   ↓ sexual self-efficacy, sexual functioning
P = C
•   PPTs, self-report ratings during pressure testing, 
thermal thresholds and  self-report ratings at 
the forearm for thermal stimuli
•   vulvar HD
•   self-report ratings for vulvar  HPT, HP-Tol
Tu et al
(2009) (49)/
Case control/
NOS (5)
Primary dysmenorrhea; 
23.1±3.03 (19-29); 
9.17±3.06 (4-16); n= 17
21.7±2.6; 
n= 16
•   Psychological assessment 
•   Regional brain metabolism/ 
activity with PET scan
P↔C
comparing pain state with the pain-free state
•   ↑ regional metabolism in thalamic, prefrontal/ 
orbitofrontal regions
Twiss et al
(2009) (73)/
Case control/
NOS (4)
Interstitial cystitis/painful 
bladder syndrome; 
45.7±3.2; PD Ø; n= 13
37.2±3.0; 
n=16
•   Psychometric measures 
•   Acoustic startle reflex (ASR)
•   Intensity and unpleasantness 
ratings of abdominal 
stimulation
P = C
•   perceptual ratings of abdominal stimulation
•   ASR during context threat and imminent threat 
conditions
P↔C
•   ↑ ASR at baseline, safe and anticipation 
conditions
•   ↑ anxiety and depression scores
Lowenstein 
et al
(2009) (55)/
Case control/
NOS (5)
Painful bladder syndrome
50 (22-69); 4 (1-20); n= 11
46 (35-54); 
n= 10
O’Leary-Sant scale
Pain catastrophizing scale
Thermal and vibratory sensory 
thresholds
Supra-threshold habituation to 
thermal stimuli
P↔C
•   ↑ thermal thresholds at T12
•   ↓ habituation to supra-threshold thermal 
stimuli
•   ↑ sensation intensity  during tonic heat stimulus
•   ↑ catastrophization
P=C
•   thermal thresholds at all testing sites except T12
•   vibratory thresholds at all testing sites
Frasson et al
(2009) (68)/
Case control/
NOS (5)
1. Primary idiopathic 
lifelong vaginismus
34.1±2.2; DD: lifelong; 
n=10
2. Vulvar vestibulitis 
syndrome accompanied by 
vaginismus; 34.6±2.6; DD: 
1-12 y; n=10
37.6±5.5; 
n=10
•   Electromyographic activity 
from pelvic floor muscles
•   Bulbocavernosus reflex 
- The fırst early response (R1)
- Second late response (R2)
•   Pudendal-nerve 
somatosensory evoked 
potentials (SEP)
•   Pudendal-nerve SEP recovery 
functions
P↔C
•   ↑ muscular activity at rest and straining
•   ↑ R2 amplitude and duration
•   ↑ cortical P40-N50 amplitude at 20 ms 
interstimulus interval
P=C
•   R1 latency, amplitude, duratıon
•   R2 latency
•   Sensory threshold to electrical stimuli on the 
dorsal nerve
•   SEP amplitudes and latencies in response to 
single stimuli
Schweinhardt 
et al
(2008) (47)/
Case control/
NOS (6)
Provoked vestibulodynia; 
25.7±5.1 (19-36); > 6 
months; SD: 5±2.9 (1-9); 
n= 14
25.6±6.0; 
n= 14
TT and PPT at the posterior 
vulvar vestibule
•   Pain intensity ratings during 
Q-tip test
•   Pain catastrophizing scale
•   Total gray matter (GM) volume
•   Regional GM densities
P↔C
•   ↓ TTs and PPTs 
•   ↑ pain intensity ratings
•   ↑ non-vulvar pain catastrophizing
•   ↑ GM density in pain modulatory and stress 
related areas
P = C
•   Total GM volume
Table 2 (cont.). Evidence table
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Studies/ 
Design/ NOS
Patients (P); Age; Pain 
Duration
Controls 
(C)
Outcome Measures Main Results
Johannesson 
et al
(2007) (60)/
Case control/
NOS (5)
Provoked vestibulodynia; 
24.9 (20-33); ≥ 6 months; 
n= 20
COC group
24.4 (18-34)
n= 20
non-COC 
group
23.8 (18-33)
n= 20
•   PPTs at peripheral sites
•   Pain intensity ratings 
•   Other measures 
P↔C
•   ↓ score on vitality and general health
•   ↑ anxiety and depression
 more bodily pain
•   Before cold pressor test
•   ↓ PPTs
During cold pressor test
•   ↓ PPTs
P=C
•   increase in PPTs during cold noxious stimulation
•   pain ratings before and during cold noxious 
stimulation
Pukall et al
(2006) (63)/
Case control/
NOS (8)
Vulvar vestibulitis 
syndrome; 27.4 (22-37); > 
6 months; SD: 86.1±55.1 
month; n=16
26.3 (21-40); 
n=16
•   Body pain questionnaire 
scores
•   General Health Problems 
questionnaire scores
•   Pain Catastrohizing 
•   Anxiety Score
•   Pain behavior, Pain intensity 
and unpleasantness ratings 
during tender point (TP) 
examination
P↔C
•   ↑ magnitude of non-vulvar pain
•   ↑ pain interference with daily activities
•   ↑ number of regularly experienced pains and ↑ 
ratings for the seriousness and interference of 
these pains and lifetime health problems
•   ↑ vulvar and non-vulvar pain catastrophizing
•   ↑ trait anxiety
•   ↑ number of painful areas during TP 
examination
 •   ↑ pain intensity and unpleasantness ratings 
during TP examination
P=C
•   Total number of lifetime health problems
•   State anxiety
Foster et al 
(2005) (71)/
Case control/
NOS (7)
Vulvar vestibulitis 
syndrome; 31.6; ≤ 4 y (for 
4 cases), 
≥ 10 y (for 6 cases); n= 10
31.9; n=10 •   Post-capsaicin pain response
•   Spontaneous pain level
•   Surface area of punctate 
hyperalgesia
 •   Surface area of dynamic 
allodynia
•   Cutaneous blood flow
•   Regional skin temperature
•   Vital signs
P↔C
•   ↑ post-injection spontaneous pain
•   ↑ area of punctate hyperalgesia
• ↑area of dynamic allodynia
•   ↑ resting pulse rate
•   ↓ resting mean systolic pressure
P = C
•   Cutaneous blood flow
 •   Regional skin temperature
Granot &Lavee
(2005) (64)/
Case control/
NOS (5)
Vulvar vestibulitis 
syndrome; 22.88±2.27; > 6 
months; n= 28
24.60±4.11; 
n= 50
•   Thermal pain threshold
•   The magnitude estimation of 
phasic suprathreshold pain
•   The magnitude estimation of 
tonic pain
•   Psychological measures
P↔C
•   ↓ pain threshold at forearm
•   ↑ magnitude estimation of phasic 
suprathreshold stimuli
•   ↑ trait anxiety
•   ↑ somatization
•   ↓ body image
P = C
•   Magnitude estimation of tonic stimuli
•   State anxiety
•   Experimental pain catastrophizing
Ness et al 
(2005) (62)/
Case control/
NOS (4)
Interstitial cystitis; 36±8; 
PD Ø; n=13
33±8; n=13 •   Psychological questionnaires
•   Thermal pain threshold and 
tolerance
•   Muscle PPT
•   Ischemic pain threshold 
(I-THR)
•   Ischemic pain tolerance 
(I-TOL)
•   The pressure and volume 
values during bladder filling 
(cystometrogram)
•   Pain intensity and 
unpleasantness ratings during 
bladder filling
P↔C
•   ↓ Quality of life
•   ↑ reactivity and hypervigilance
•   ↑ catastrophizing
•   ↓ muscle PPTs
•   ↓ I-TOL
•   ↑ bladder sensitivity 
P = C
•   Thermal measures
•   I-THR
Table 2 (cont.). Evidence table
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Studies/ 
Design/ NOS
Patients (P); Age; Pain 
Duration
Controls 
(C)
Outcome Measures Main Results
Laursen et al
(2005) (57)/
Case control/
NOS (8)
1. Fibromyalgia/Whiplash/
46 (37-54)/ 53 months/ 
n=10
2. Endometriosis; 44 (35-
61); 96 months; n=10
3. Low back pain; 45 (28-
58); 48 months; n=10
4. Rheumatoid arthritis; 43 
(28-58); 42 months; n=10
42 (25-61); 
n=41
•   Pain intensity of the habitual 
pain 
•   PPTs
•   Quality of life score
P1,2,3,4↔C
•   ↑ habitual pain intensity
 •   ↓ PPTs
P1=P2=P3=P4
•   median PPT values
P1↔P2,3,4
•   ↑ habitual pain intensity
Pukall et al
(2005) (48)/
Case control/
NOS (8)
Vulvar vestibulitis 
syndrome; 25.7 (19-39); > 6 
months; n=14
25.7 (19-39); 
n= 14
•   Intensity and unpleasantness 
ratings during mild 
and moderate pressure 
stimulation
•   Regional brain activity 
during non-painful and 
painful stimuli with FMRI
P↔C
•   ↑ intensity and unpleasantness ratings
•   ↑ activation of pain-related brain regions
Granot
(2005) (65)/
Case control/
NOS (6)
Vulvar vestibulitis 
syndrome; 24.1±4.1 (18-
36); > 6 months; n= 98
23.3±2.4 
(18-31)
n= 135
•   Personality traits 
- harm avoidance (HA)
- novelty seeking (NS)
- reward dependence (RD)
•   Thermal pain threshold
•   The magnitude estimation 
of perceived phasic supra-
threshold pain (VAS)
P↔C
•   ↓ Thermal pain thresholds
•   ↑ VAS scores in response to the supra-threshold 
painful stimuli
•   ↑ Scores in HA and RD
P = C
•   Scores in NS
•   Sig. correlations between pain sensitivity  and 
personality trait variables (HA and RD)
Giesecke et al
2004 (58)/
Case control/
NOS (8)
Vulvodynia; 33.41±9.39 
(18-60); PD Ø; n= 17 37.17±11.43; 
n= 23
•   PPTs in the vulvar areas
•   PPTs at peripheral sites
•   The pressures required to 
produce different levels of 
subjective pain at the thumb
P↔C
•   ↓ PPTs in the vulvar region
•   ↓ PPTs at peripheral sites
•   ↓ pressures required to elicit faint, mild and 
slightly intense pain at the thumb
Bajaj et al
(2003) (52)/
Case control/
NOS (5)
Endometriosis; 37.7±2.9; 
15±3.5; n= 10
30.1±2.3; 
n=10
•   Post-saline pain intensity 
(VAS)
•   Post-saline pain areas
•   PPTs and TTs before and 
after injection
P↔C
•   ↑Peak pain VAS after injection into the first 
dorsal interosseus muscle (FDI) of the hand
•   ↑ Post-saline pain areas after injection into the FDI
•   ↓ PPTs and before and after injection
P = C
•   Peak pain VAS after injection into the back
•   Post-saline pain areas after injection to the back 
•   TTs before and after injection
Granot et al
(2002) (66)/
Case control/
NOS (5)
Vulvar vestibulitis 
syndrome; 27.1±7.6; PD 
Ø; n= 44
25.4±5.2; 
n= 41
•   Anxiety scores 
•   Heat pain intensity and 
unpleasantness thresholds
•   The magnitude of perceived 
intensity and unpleasantness 
of phasic and tonic supra-
threshold stimuli
•   The cardiovascular 
parameters
P↔C
•   ↑ state anxiety, trait anxiety
•   ↓ heat pain and unpleasantness thresholds
•   ↑ magnitude estimation of supra-threshold  
phasic pain  and ↑ unpleasantness ratings at 
47ºC and 48 ºC.
•   ↑ scoring of tonic pain perception and ↑ 
unpleasantness ratings
•   ↑ increase in systolic blood pressure during 
tonic pain stimuli
P=C
•   Magnitude estimation of perceived intensity 
and unpleasantness at 44ºC, 45ºC and 46ºC
•   Heart rate
Bajaj et al
(2002) (61)/
Case control/
NOS (4)
Dysmenorrhea; 25.5±1.1; 
PD Ø; n= 20
28±1.9
n= 15
•   McGill Pain Questionnaire
•   PPT, PiPT, HPT, TT
P↔C (menstrual phase)
•   ↓ HPT at the control sites
•   ↓ PPT at referral and control sites
P = C (menstrual phase)
•   HPT at referral areas
Menstrual phase↔other phases
•   ↓ HPT and PPT at referral and control areas
Menstrual phase↔ovulatory phase
•   ↓ PiPT
Table 2 (cont.). Evidence table
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Studies/ 
Design/ NOS
Patients (P); Age; Pain 
Duration
Controls 
(C)
Outcome Measures Main Results
Pukall et al 
(2002) (51)/ 
Cohort/
NOS (8)
Vulvar vestibulitis 
syndrome; 25.85 (21-44); 
> 6 months; 50.08±38.37 
month; n= 13
26.31 (21-
41); n= 13
•   Pain ratings during 
gynecological examination
•   Tactile and PPTs
•   Pain and distress ratings 
during supra-threshold pain 
and sustained pressure
•   PP-Tol at peripheral sites
•   Psychological measures 
P↔C
•   ↑pain ratings during gynecological examination
•   ↑ catastrophization scores related to intercourse 
pain
•   ↓ TT and PPT for the vestibular sites and 
labium minus
•   ↓TT, PPT and PP-Tol over the deltoid muscle
•   ↑ distress ratings for supra-threshold pain and 
sustained pressure
P = C
•   TT at forearm and tibia
•   PPT at tibia
session 1= session 2
•   TTs at vestibular sites, thigh and labium minus
session 2↔session 1
•   ↑ mean PPTs of vestibular sites
Granot et al
(2001) (67)/
Case control/
NOS (4)
Dysmenorrhea; 23.7±2.8; 
PD Ø; n= 22
24.1±3.1 (19-
30); n= 31
•   Anxiety scores 
•   Self-reports of pain
•   HPT
•   Supra-threshold magnitude 
of perceived pain (VAS)
•   Pain-evoked potentials 
by laser stimuli (latency, 
amplitude) 
•   VAS score in response to 
supra-threshold laser
P↔C
•   ↑ state anxiety
•   ↑ VAS score for supra-threshold pain
•   ↑ latency of the laser-evoked potentials
•   ↑ VAS score in response to supra-threshold 
laser stimuli
P=C
•   Trait anxiety
•   HPT
•   Amplitude of the laser-evoked potentials
Giamberardino 
et al 
(1997) (69)/
Case control/
NOS (5)
Dysmenorrhea; 29±5.6; 
PD Ø; n= 10
28.7±5.9 ; 
n= 10
•   EPT of skin, subcutis and 
muscle
P↔C
•   ↓ EPT of subcutis and muscle
P=C
•   EPT of skin
Clauw et al 
(1997) (59)/
Case control
NOS (6)
Fibromyalgia; 43.8; PD Ø; 
n= 60
Interstitial cystitis; 44; PD 
Ø; n= 30
45.6; n= 30 •   Questionnaire regarding 
current symptomatology
•   PPT
•   PP-Tol
IC↔C
•   ↓ PPT, PP-Tol at tender and control points
FM↔IC
•   ↓ PPT, PP-Tol at tender points
FM = IC
•   Frequency of current symptoms
•   PPT, PP-Tol at control points
(COC: Combined Oral Contraceptive, CPP: Chronic Pelvic Pain, DD: Disease Duration, DNIC: Diffuse Noxious Inhibitory Control, EPT: Electri-
cal Pain Threshold, FMRI: Functional Magnetic Resonance Imaging, HD: Heat Detection, HPT: Heat Pain Threshold, HP-Tol: Heat Pain Tolerance, 
PET: Positron Emission Tomography, QST: Quantitative Sensory Testing, PPT: Pressure Pain Threshold, PP-Tol: Pressure Pain Tolerance, PiPT: 
Pinch Pain Threshold, PD: Pain Duration, SD: Symptom Duration, TT: Tactile Threshold, VAS: Visual Analog Scale)
Table 2 (cont.). Evidence table
Risk of Bias and Level of Evidence
The methodological quality ratings of the reviewed 
studies are presented in Table 2. In most cases (91.57% 
or 239 of the 261 items), the 2 researchers agreed. After 
a second review and a discussion of the 22 differences, 
the raters reached a consensus for 21 items. The last 
author (MM) solved the remaining point of difference. 
Methodological scores ranged from 4 to 8 points 
(maximum score 9). The most common flaws for the 
case control studies were the representativeness of the 
patients and the comparability of cases and controls.
Since all studies are observational (case-control 
or cohort) in the present systematic review, the level 
of evidence for each relevant outcome began as low-
quality evidence according to the GRADE system. Then, 
for most of the outcomes, the quality of evidence was 
downgraded to low quality or to very low quality due 
to the limitations of the study design (risk of bias) and 
inconsistency of the study results. 
Evidence for Central Sensitization
In the following section, the results of this review 
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Although the differences in brain activity increases 
during the menstrual phase were not significant be-
tween the groups, deactivation of brain regions in 
response to noxious thermal stimulation of the control 
site was observed in control women but not in dys-
menorrheic women. In response to stimulation of pain 
referral site, dysmenorrheic women had higher activ-
ity in the left entorhinal cortex and inferior/middle 
temporal gyrus than controls during non-menstrual 
phases (without background pain) (50). Women with 
VVS showed higher activation in the right cerebellum 
during non-painful tactile vestibular stimulation and 
higher activation in the insular and frontal cortical re-
gions during painful stimulation compared to control 
subjects (48).
There is a change in brain activity/function in 
patients with urogynecological CPP (very low level of 
evidence) but the evidence is too limited to draw con-
clusions concerning the regions. 
Alteration in Sensory Perception 
Tactile Stimuli
Three research papers with low (51) and moderate 
risk of bias (47,52) examined the response to tactile 
stimuli with von Frey filaments. Although Bajaj et al 
(52) did not find any significant difference between 
groups for punctate tactile thresholds at referral and 
nonreferral areas of menstrual pain, other studies re-
ported lower punctate tactile thresholds at vestibular 
sites (47,51), labium minus, and over the deltoid muscle 
but not at other peripheral sites (forearm, tibia) in PVD 
patients and these results were reliable over time in 
symptomatic areas (51). 
In patients with PVD, higher distress ratings to 
sustained supra-threshold pain stimuli in the vestibular 
region (51) and higher pain intensity ratings during 
cotton-swab test (47,51,53,54) and speculum insertion 
(53,54) were also established.
The evidence based on the selected articles is 
limited and too conflicting to draw conclusion for the 
response to tactile stimuli in patients with urogyneco-
logical CPP (very low level of evidence).
Vibratory Stimuli 
In response to vibratory stimuli, 2 studies with 
moderate (55) to high risk of bias (56) did not provide 
evidence for the hypersensitivity at both local and 
remote dermatomes in patients with painful bladder 
syndrome (PBS) (55) and vulvodynia (56).  
are categorized according to the neural, neurophysi-
ological, and clinical correlates of CNS alterations.
Alteration in Brain Morphology and Function
Brain Morphology
Using voxel-based morphometry, 3 studies with 
moderate risk of bias reported changes in regional gray 
matter (GM) density/volume in patients having CPP 
with and without endometriosis and in the other CPP 
conditions including primary dysmenorrhea and pro-
voked vestibulodynia (PVD) (synonym “vulvar vestibu-
litis syndrome”) (17,46,47). Schweinhardt et al (47) re-
ported only regionally increased GM density compared 
to both GM volume decreases and increases in other 
studies (17,46). Studies reported greater decreases in 
GM volume in regions of the pain system including 
thalamus, cingulate cortex, putamen (17), precuneus, 
secondary somatosensory cortex, superior temporal 
gyrus, cerebellum (46), and insular cortex (17,46) and/or 
those involved in pain modulation (prefrontal cortex) 
(17,46) in patients compared to controls. Endometriosis 
patients without CPP and PVD patients showed no evi-
dence of a GM decrease within the pain system (17,47). 
Regional increase in GM density/volume was found in 
pain modulatory, stress, and endocrine function related 
areas including right inferior/middle frontal gyrus, left 
amygdala (17), cingulate cortex,  hypothalamus,  precu-
neus, superior/middle temporal gyrus, cerebellum (46), 
mesencephalon (17,46), basal ganglia (47), and hippo-
campus/parahippocampus (46,47).  
There is limited evidence suggesting the change 
in regional brain morphology in patients with urogy-
necological CPP, but location and direction (increase or 
decrease) are conflicting (very low level of evidence). 
Brain Function
Two different imaging methods were used to ex-
amine CNS activity in 3 studies with low (48), moderate 
(49), or high risk of bias (50). Using fluoro-deoxyglucose 
positron emission tomography, Tu et al (49) found that 
cramping menstrual pain is associated with increased 
activity in prefrontal/orbitofrontal regions and left 
ventral posterior thalamus and with decreased activity 
mainly in sensorimotor regions of left hemisphere in 
patients with primary dysmenorrhea.
Functional magnetic resonance imaging was used 
to investigate the cerebral response to experimental 
thermal and tactile stimuli in patients with dysmenor-
rhea (50) and vulvar vestibulitis syndrome (VVS) (48). 
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Evidence regarding the use of vibratory stimuli is 
too limited, but hypersensitivity to vibratory stimuli 
does not seem to be present (very low level of evidence).
Pressure Stimuli
Pressure algometry was used as one of the outcome 
measures in 10 of the 29 studies with low (51,57,58), 
moderate (47,52,53,59,60), or high risk of bias (61,62). 
One study with low risk of bias also used manual tender 
point examination (63). 
Schweinhardt et al (47) assessed pain thresholds 
in response to pressure at only the symptomatic site 
(vestibular site) in their brain morphometry study and 
provided evidence for primary hyperalgesia. All remain-
ing studies examined both local and remote (52,53,57-
59,61) or remote sites only (51,60,62,63) and all of 
them except one (53) established widespread pressure 
hyperalgesia in women with urogynecological CPP (see 
Table 2 for details). 
Pukall et al (51) assessed the genital thresholds 
also in a second session (3-12 months later) to test the 
stability of thresholds over time and reported a similar 
increase in punctate pain thresholds in the PVD and 
control groups. This increase at the second session can 
be explained by reduced anxiety focused on the testing 
because of the familiarity with the test procedure.
There are 2 studies comparing CPP patients with 
other chronic pain patients (57,59) such as fibromyal-
gia/whiplash, low-back pain, and rheumatoid arthritis 
patients. No significant differences were reported in 
median pressure pain thresholds between endometrio-
sis patients and other chronic pain patients (57). In the 
other study, compared to fibromyalgia patients, women 
with interstitial cystitis reported higher pressure pain 
thresholds at tender points (9 paired areas) but not at 
control points (59).
The presence of generalized hyperalgesia in re-
sponse to pressure stimuli is supported by a low level of 
evidence in women with urogynecological CPP.
Thermal Stimuli
Thermal stimuli were used in 10 studies, with mod-
erate (53-55,64-66) to high risk of bias (50,61,62,67), to 
evaluate CS in women suffering from urogynecological 
CPP. All studies examined the response to heat stimuli at 
both local and remote sites (50,53,55,61) or at remote 
sites only (54,62,64-67). Five of them (50,61,64-66) pro-
vided evidence for widespread thermal hyperalgesia, 
while 2 others did not (53,62). Besides this, inconsistent 
results at peripheral sites (54,67) and hypoesthesia at 
pain-referral area (55) were also reported (see Table 2 
for details). 
PVD patients showed peripheral hypersensitiv-
ity for pain tolerance but not for pain thresholds (54). 
Even though Granot et al (67) did not report decreased 
heat pain thresholds at the thenar eminence of the 
hand of dysmenorrhea patients, the authors reported 
higher magnitude estimations on a visual analog scale 
of supra-threshold pain elicited by thermal and water-
cooled CO2 laser stimuli to the hand. 
Elevated thermal detection thresholds, indicative 
for the presence of hypoesthesia, were established at 
the suprapubic area but not at remote dermatomes 
in patients with painful bladder syndrome (55). In 
the same study, supra-threshold thermal stimuli were 
also applied at T12 (suprapubic) and S3 (remote) der-
matomes for 60 seconds to assess the habituation to 
somatic stimuli. The authors found that habituation 
to suprathreshold stimuli is less common in patients 
than in controls, suggesting the impaired habitua-
tion (55). 
There is conflicting evidence regarding the re-
sponse to thermal stimuli in patients with urogyneco-
logical CPP, although the majority suggest widespread 
thermal hyperalgesia (very low level of evidence).
Electrical Stimuli
There are 4 papers with moderate risk of bias as-
sessing the response to electrical stimuli (18,68-70). No 
hypersensitivity was reported at local (68) or at asymp-
tomatic sites for electrical detection thresholds (70). 
Giamberardino et al (69) investigated the electrical 
pain thresholds (EPT) at 3 stimulus depths: skin, sub-
cutis, and muscle tissue within the uterine visceretome 
and on the limbs, and reported similar thresholds for 
skin, and lower thresholds for subcutis and muscle 
compared to controls. EPTs were  also examined in 
patients with endometriosis before and following 
excisional surgery for all visible endometriotic lesions 
(70). Three and 6 months after surgery, it is reported 
that patients’ generalized hyperalgesia to electrical 
stimuli significantly and progressively improved, along 
with their dysmenorrhea severity. In another study by 
Neziri et al (18), EPTs during sural nerve stimulation 
were significantly lower in patients with endometrio-
sis than in controls, also demonstrating the general-
ized hyperalgesia. 
There is evidence supporting the generalized elec-
trical hyperalgesia in patients with urogynecological 
CPP (low level of evidence). 
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Injection of Specific Pain Mediators
In one study with moderate risk of bias, after 
intradermal injections of capsaicin in the forearms 
and feet of VVS patients, they reported greater spon-
taneous pain, area of punctate hyperalgesia, and 
dynamic allodynia compared with pain-free controls 
(71). In another study with moderate risk of bias (52), 
patients with endometriosis reported higher pain 
intensity and larger pain areas after injection of hy-
pertonic saline to the control site (into the first dorsal 
interosseus muscle of the hand). These hyperalgesic 
responses were not observed following the injection 
to the menstrual pain referral site (the multifidus 
muscle at the low back). 
The limited available evidence suggests the pres-
ence of CS in women with urogynecological CPP with 
increased response to injection of pain mediators (very 
low level of evidence). 
Ischemic Stimuli
The ischemic pain test (IPT) is a tonic pain stimulus 
involving multiple noxious input (e.g., pressure and 
ischemia) (70). Two studies with moderate (70) to high 
risk of bias (62) used a modified procedure and provid-
ed conflicting evidence for the presence of generalized 
hyperalgesia. In the study of He et al (70), endome-
triosis subjects had significantly higher IPT visual analog 
scale scores than controls, but after removing ectopic 
implants with surgery, their IPT scores were significantly 
and progressively improved. Six months after surgery, 
there was no difference in IPT scores between patients 
and controls anymore. 
Ness et al (62) showed that the subjects with in-
terstitial cystitis tolerated the ischemic forearm pain 
(ischemic tolerance) for a shorter duration than normal 
subjects, while the difference was not statistically sig-
nificant for the ischemic threshold duration. 
The evidence in response to ischemic stimuli in pa-
tients with CPP is too limited and conflicting (very low 
level of evidence). 
Distention Stimuli
One study (62) with high risk of bias used cystomet-
rogram to assess bladder sensitivity, and reported that 
the subjects with interstitial cystitis are more sensitive 
to bladder distention than healthy subjects, demon-
strating the presence of primary hyperalgesia. 
There is limited evidence that sensitivity to disten-
tion stimuli in CPP patients is increased (very low level 
of evidence).
Neurophysiological Changes
Overactive Bottom-up Mechanisms
Four studies with moderate (18,68) to high risk of 
bias (56,67) evaluated excitability and responsiveness of 
the CNS by using different kinds of neurophysiological 
tests. 
The spinal withdrawal reflex was used to evaluate 
reflex receptive fields of spinal cord neurons in patients 
with endometriosis associated CPP. In comparison with 
pain-free participants, patients showed larger reflex 
receptive fields on the foot sole, providing evidence 
for the expansion of nociceptive reflex receptive fields. 
Lower thresholds to induce subjective feelings of in-
creasing pain sensation and lower nociceptive reflex 
thresholds by repeated electrical stimulation (temporal 
summation) of the cutaneous area of the sural nerve 
were even so reported, indicating generalized spinal 
cord hypersensitivity and generalized facilitated tem-
poral summation (18). 
CNS excitability was also assessed by measuring 
electromyographic activity of pelvic floor muscles, 
bulbocavernosus reflex (BCR), and pudendal nerve so-
matosensory evoked potentials in women with primary 
idiopathic lifelong vaginismus. In comparison with the 
healthy controls, the patients had greater electromyo-
graphic activity, higher amplitude and duration for the 
one component of bulbocavernosus reflex, and higher 
amplitude of cortical P40-N50 in the pudendal nerve so-
matosensory evoked poatentials recovery cycle. This ab-
normal excitability suggests concomitant CNS changes 
in vaginismus (68). 
Patients with dysmenorrhea showed longer laten-
cies of pain-evoked potentials and higher pain ratings 
in response to supra-threshold pain evoked by the laser 
stimuli to a non-gynecological site (67).
On the other hand, compared with healthy controls 
and patients with a shorter history of pain, vulvodynia 
patients with a longer history of pain demonstrated a 
significantly reduced effect of adaptation on sensory 
perception, suggesting central hyperexcitability (56). 
Available evidence suggests overactivity of bottom-
up CNS mechanisms in the pathophysiology of urogyne-
cological CPP (low level of evidence).
Dysfunctional Top-down Mechanisms
Two studies with moderate risk of bias found no 
evidence of impaired diffuse noxious inhibitory control 
response in patients with PVD. There was no significant 
difference in the number of diffuse noxious inhibi-
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tory control responders between the groups (54,60). The 
magnitude of the response (increase in pressure pain 
threshold) was similar in both patients and controls in 
one of the studies (60), while the other study (54) report-
ed a higher magnitude of response (increase in heat pain 
tolerance) in patients with PVD as compared to controls.
Evidence suggests an intact diffuse noxious inhibi-
tory control function in patients with PVD (low level of 
evidence). 
Dysfunction of Hypothalamic-pituitary-adrenal 
(HPA) Axis
Only one study which has a high risk of bias inves-
tigated whether menstrual pain is a sufficient stressor 
to affect HPA axis function. Women with dysmenor-
rhea had significantly lower mean cortisol levels than 
controls. Also, a significant negative correlation was 
observed between the number of years that dysmen-
orrhea had been present and the mean serum cortisol 
levels (50).
There is limited evidence to support the dysfunc-
tion of the HPA axis in urogynecological CPP (very low 
level of evidence).
Alteration in Psychosocial Functioning
Psychological factors such as anxiety, somatiza-
tion, catastrophizing, and other personality traits are 
involved in pain processing (64) and enhanced pain 
facilitation may be caused by cognitive emotional sen-
sitization (72). Eight studies with low (51,63), moderate 
(47,53,60,64,65), or high risk of bias (73) reported con-
flicting results regarding the alteration of psychosocial 
functioning and/or its association with pain perception. 
In 3 studies, no association was found between higher 
anxiety scores and pain response in patients with PVD 
(60,64) or interstitial cystitis/painful bladder syndrome 
(73). Other components of psychosocial function includ-
ing somatization and catastrophization were examined 
in a variety of ways in women with PVD and results 
have demonstrated that affected women report more 
somatic and/or catastrophic symptoms in comparison to 
control women (47,53,63,64), suggesting that a higher 
tendency to catastrophize about pain may enhance the 
pain perception and increase emotional distress related 
to pelvic pain syndromes (63). Two studies reported an 
association between enhanced pain perception and 
psychological factors (53) and personality traits (65) in 
women with VVS. On the other hand, Granot and Lavee 
(64) found 4 subgroups of VVS women on the basis of 
high/low anxiety and high/low pain perception, indi-
cating that not all women with VVS have greater pain 
sensitivity and anxiety levels. What’s more, women with 
VVS were more sensitive to noxious stimuli regardless 
of their personality traits (65). 
Besides certain psychological factors, the role of 
self-efficacy and body image in the perception of pain 
was investigated in 2 studies (53,64). The VVS women 
demonstrated lower body image, lower sexual func-
tioning, and lower sexual self-efficacy than controls 
associated with higher pain perception at vulvar and 
peripheral sites. 
Twiss et al (73) examined the acoustic startle 
responses, which is mediated by output from the 
amygdala complex, to investigate the responsiveness 
of affective circuits during visceral related threat. The 
women with interstitial cystitis/painful bladder syn-
drome showed significantly greater startle magnitudes 
than controls during non-imminent threat conditions, 
indicating increased activation of a defensive emo-
tional circuit and so hypersensitivity to visceral stimuli.
As mentioned in the first part of the results section 
of this review, the brain imaging studies also point to 
the importance of cognitive emotional sensitization 
with changes in morphology and activity of brain re-
gions involved in pain modulation, cognition, stress, 
and emotions (17,46-50).
Although there are changes in psychosocial func-
tioning of women with urogynecological CPP (very 
low level of evidence), the literature for the associa-
tion of them with pain perception is too limited and 
inconclusive. 
Autonomic Dysregulation
One study with moderate risk of bias showed that 
VVS cases had higher heart rates and lower systolic 
blood pressures in the resting state compared to pain-
free controls. Following capsaicin injection, systolic 
blood pressure and mean arterial blood pressure in VVS 
patients increased more rapidly compared to controls 
(71). This autonomic hyperactivity was confirmed by an-
other study with moderate risk of bias, which showed 
higher increase in systolic pressure during heat pain 
stimuli in the same patient group (66).
Autonomic dysregulation has been shown in 2 
studies in women with urogynecological CPP (very low 
level of evidence). 
Menstrual Phase Variations
There are 4 studies with moderate (69) to high 
risk of bias (50,61,67) regarding the influence of the 
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menstrual phase on pain perception in dysmenorrheic 
women. Studies reported inconsistent results for the 
pain sensitivity in menstrual pain referral or control 
sites with different types of stimulation, including pres-
sure, pinch, heat, laser, or electrical.  Although Bajaj 
et al (61) reported higher sensitivity in the menstrual 
phase, no menstrual cycle effect was observed in the 
other 2 studies for the heat stimulation (50,67). Lower 
sensitivity, not for tactile, but for pressure and pinch 
stimuli, was also demonstrated by Bajaj et al (61) dur-
ing the menstrual phase. In response to laser stimuli, 
dysmenorrhea patients had the longest latency and 
the highest amplitude of pain-evoked potentials (that 
is higher pain sensitivity) during the follicular phase, 
whereas the shortest latency and the lowest amplitude 
were observed in the luteal phase (67). Another study 
examined the pain response to electrical stimuli at 
3 stimulus depths (skin, subcutis, and muscle) and re-
ported higher pain sensitivity during the periovulatory 
phase for skin and during the perimenstrual phases for 
muscle and subcutaneous tissue (69).
The available evidence regarding the effect of 
menstrual cycle phase on pain perception in women 
with urogynecological CPP is limited and inconclusive.
discussion
The present study systematically reviewed scientific 
literature addressing central hypersensitivity in women 
with urogynecological CPP. The mechanisms contribut-
ing to pain amplification and chronicity in urogyneco-
logical CPP seems heterogeneous and likely to occur at 
various levels of the nervous system. 
Voxel-based brain morphometry studies appear to 
agree with changes in regional brain morphology of 
women with urogynecological CPP, regardless of the 
direction of change (increases and decreases in gray 
matter density/volume) (17,46,47). Variability of the 
results between studies may be attributed to many fac-
tors such as the etiology of pain, pain duration, pain 
occurrence (intermittent vs. persistent), patient charac-
teristics (age, personality traits), and pain medications 
(17,46,47). The stress on pain processing systems might 
be less in menstrual or provoked pain than in continu-
ous pain and this might affect the direction of gray 
matter changes (47). In addition, gray matter changes 
may be dynamic and may change over time within an 
individual. The initial increase in gray matter as an acute 
adaptive mechanism may be followed by a decrease in 
gray matter depending on the duration and persistence 
of the nociceptive input (17). Thus, longitudinal studies 
are required to evaluate possible bi-directional changes 
of gray matter in the progression of urogynecological 
CPP.
Besides change in brain morphology, studies also 
report alteration in brain function in patients suffering 
from urogynecological CPP. Hypersensitivity associated 
with urogynecological CPP is reflected in increased ac-
tivation (48-50) or no deactivation (50) in pain related 
brain regions. In dysmenorrhea patients, absence of 
significant deactivations of certain pain related brain 
regions in response to noxious stimulus in the men-
strual phase can be attributed to dysmenorrhea-pain 
associated maximally deactivated brain regions where 
deactivation would usually occur during pain experi-
ence (74), so further deactivation  in response to a 
noxious heat stimulus is not observed. Alternatively, 
alterations in resting state activity may be present in 
women with dysmenorrhea (50). One study also re-
ported regional cerebral hypometabolism in somatic 
sensorimotor regions as well as hypermetabolism in 
thalamo-orbitofrontal-prefrontal regions during 
cramping menstrual pain (49). This hypometabolism 
may display a compensatory inhibitory mechanism in 
response to excitatory input and the generalized hy-
peralgesia in primary dysmenorrhea (67,69). Although 
existing evidence suggests increased activation in pain-
related brain regions in women with urogynecological 
CPP, further investigation of other observations (lack of 
deactivation, hypometabolism) in certain brain regions 
requires further study specifically adressing activity in 
these regions.  
In most of the included studies, different methods 
were used to establish primary and secondary hyper-
algesia. Reflex hypersensitivity at outside of the area 
of pain in response to repeated electrical stimulation 
indicates generalized facilitated temporal summa-
tion in patients with menstrual pain (18). Enhanced 
post-capsaicin and post-saline pain responses extend-
ing far beyond the anatomic location of the primary 
complaint may also reflect an expanded field of neural 
hypersensitivity consistent with the presence of CS in 
VVS and endometriosis (52,71). Nevertheless, revers-
ibility of generalized hyperalgesia is suggested, given 
the normalization after surgical removal of peripheral 
nociceptive sources (70). Therefore, further research 
is warranted to assess whether the presence of clini-
cal pain and tissue damage is the crucial factor in the 
manifestation of CS. 
One study also reported cutaneous hyposensitivity 
at the pain referral area in patients with painful blad-
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der syndrome (55). This hyposensitivity is thought to 
reflect either activity of the diffuse noxious inhibitory 
control system (75) and/or adaptation (69), in which 
additional stimuli are perceived as relatively mild be-
cause they occur against a background of chronic pain 
(55). Findings of impaired habituation to non-noxious 
stimuli in local and remote dermatomes in the same 
patient group may also underlie increased awareness 
of visceral events and may facilitate chronic pain (55). 
In general, findings for the presence of generalized 
hyperalgesia are inconclusive because of the differences 
in the nature of these pain syndromes or differences in 
the methodology of studies. Available evidence seems 
to suggest generalized hyperalgesia in response to 
pressure and electrical stimuli and injection of capsaicin 
and hypertonic saline, but the response to other stimuli 
such as tactile, vibratory, thermal, ischemic, and disten-
tion, definitely deserves further attention.
Neurophysiological studies also proved overactivity 
of bottom-up mechanisms. Reduced adaptation metrics 
may indicate increased hyperexcitability in longstand-
ing vulvodynia (56). The generalized hyperexcitability is 
reported to be associated with an increased number of 
responsive spinal neurons or with an expansion of the 
receptive fields of the spinal neurons (18). In patients 
with vaginismus or VVS accompanied with vaginismus, 
concomitant CNS changes may be understood from 
abnormal and excessive functioning of pelvic floor 
muscles, reduced inhibition of cortical somatosensory 
evoked potentials, and hyperexcitable bulbocaverno-
sus reflex (68). The increased latency of pain-evoked 
potentials by laser stimuli to the hand also confirm the 
systemic phenomenon rather than a regional change 
in the pelvis of dysmenorrheic women (67). The limited 
number of studies with a wide variation of assessment 
methods requires further neurophysiologic research to 
confirm these results.
The intact diffuse noxious inhibitory control in 
vulvodynia patients may be explained by provoked or 
intermittent pain (with pain-free intervals) of this pa-
tient group. It is possible that diffuse noxious inhibitory 
control dysfunction may play less of a role in chronic pain 
conditions in which the pain is recurrent (54,60). Zhang 
et al (56) also suggest that women with vulvar pain for a 
long duration or with unprovoked pain have more CNS 
involvement or dysregulation.  Alternatively, an excess 
in descending facilitatory mechanisms may provide an 
explanation for the pain experienced in PVD (60). 
Although an altered psychosocial and sexual pro-
file in women with VVS (or PVD) and interstitial cystitis/
painful bladder syndrome has been reported in several 
studies, only 2 studies demonstrated that augmented 
pain perception is associated with psychological fac-
tors (53) and personality traits (65). On the other hand, 
reported changes in brain morphology and function 
may be responsible not only for the development and/
or maintenance of the chronic pain, but might also 
contribute to other common comorbid clinical features, 
such as mood disorders and cognitive impairment (17). 
Nonetheless, it is clear that more research is warranted 
to define the precise influence of psychological factors 
on the central pain processing. 
It is reported that the menstrual phase, segmental 
site, dysmenorrhea status and depth, and modality of 
pain stimulation all have interacting effects on pain 
sensitivity (61,67,69). The inconsistent results of men-
strual cycle effects may be partly due to the lack of 
confirmation of ovulation (61). Well-designed future 
studies are needed in order to more fully explain these 
interactions on central pain sensitivity.
The same goes for the precise mechanism of auto-
nomic dysregulation and association between pain and 
blood pressure.
Women with VVS have been shown to have an 
elevated heart rate and reduced systolic pressure in the 
resting state (71) and higher increase in systolic blood 
pressure in response to experimental pain stimuli  sug-
gesting an autonomic dysregulation (66,71). In pain-
free subjects, reduced blood pressure has also been 
shown to be associated with increased pain thresholds 
(76).
Given the inconclusive findings and the low levels 
of evidence in the present review, due to the observa-
tional study designs, definitely more research is war-
ranted to draw conclusions regarding CS in CPP. In most 
of the studies, there is also a lack of information about 
particular factors (comorbid chronic pain syndromes, 
psychiatric conditions, use of analgesic medication 
before or during study period, menstrual cycle regu-
larity, oral contraceptive use) known to be involved in 
pain processing. The variation in study results can be 
attributed to not only these factors, but also different 
diagnoses of CPP, using a variety of assessment meth-
ods, frequency of pain, pain duration, age, and person-
ality characteristics of study participants. The design 
of included studies does not allow us to state whether 
altered brain morphology and function, generalized 
hypersensitivity, or impaired psychosocial functioning 
arise from the experience of CPP, or whether they pre-
dispose a patient to CPP. Without longitudinal studies, 
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it is not possible to know whether these alterations are 
a cause or an effect of pain. Based on these method-
ological issues, further study designs with a sufficient 
and justified sample size are needed. 
The recognition of the possible involvement of 
CS has important implications for the development of 
specific therapies and better clinical management of 
urogynecological CPP. The traditional practice of fo-
cusing on peripheral pathology may not be adequate 
and needs to be analyzed carefully since several CNS 
dysfunctions are now indicated in women with urogy-
necological CPP. A multidisciplinary approach is needed 
to understand pain variability in this chronic pain syn-
drome, in which cognitive and emotional factors may 
play a role together with augmented pain sensitivity. 
But also, these hypotheses should be the subject of 
future studies. 
Up to now, it seems that generalized hyperalgesia 
is present in response to pressure and electrical stimuli 
and bottom-up nociceptive mechanisms are overactive, 
given the enhanced reflex responses and temporal 
summation. Also, brain function and brain activation 
changes are revealed in CPP patients, but the direction 
and the localization deserves further attention. 
On the other hand, evidence for impaired top-
down mechanisms (pain inhibition or pain facilitation) 
is inconclusive. The limited evidence for diffuse noxious 
inhibitory control indicates intact function of this con-
trol, and also the role of psychological factors in pain 
facilitation is not clear and consistent.
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